بوابة الفجر
بوابة الفجر
Ready to play
Ready to play
This article reviews the Egyptian Drug Authority's strategy to strengthen the local pharmaceutical industry through the localization of pharmaceutical manufacturing, reflecting the regulatory and industrial development in Egypt. The authority is adopting a project to localize 38 strategic products, including biologics, orphan drugs, and medical raw materials, with the aim of supporting the domestic market, facilitating technology transfer, and ensuring a stable supply of medicines for citizens. It also focuses on enhancing partnerships with international companies, providing investment incentives to boost Egypt's position regionally and globally as a pharmaceutical manufacturing hub. Additionally, it organizes international events such as Pharmaconex Expo, which showcases the country's competitive capabilities and aims to attract investments and facilitate knowledge exchange.
Notice: This Is an AI-Generated Summary
Comments (0)